Target Sennosides 8.6 mg Tablets

Manufacturer: TARGET CORPORATION | TIME CAP LABORATORIES, INC. | TIME CAP LABORATORIES INC
Effective date: 2024-08-22
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 00:17:38

Label at a glance#

ProductSENNA LAXATIVE

Active ingredientSENNOSIDES A AND B

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces bowel movement in 6-12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage adults and children 12 years of age and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years ½ tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor

Storage and handling

each tablet contains: calcium 25 mg, sodium 2 mg (VERY LOW SODIUM) store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-800-910-6874

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)
generally produces bowel movement in 6-12 hours

Warnings

WARNINGS SECTION

Do not use laxative products for longer than 1 week unless directed by a doctor

Do not use

OTC - DO NOT USE SECTION

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	½ tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 25 mg, sodium 2 mg (VERY LOW SODIUM)
store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-800-910-6874

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sennosides-100s-labelsennosides-100s-ifc

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
312935	sennosides 8.6 MG Oral Tablet	PSN	4
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	4
312935	sennosides A and B 8.6 MG Oral Tablet	SY	4

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
11673-191-01	SENNA LAXATIVE	100 in 1 BOTTLE	TABLET	100		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
11673-191	SENNA LAXATIVE (SENNOSIDES 8.6 MG) TABLET [TARGET CORPORATION]	4	Current NDC, Legacy NDC, 1 package rows	20240823_7cab058f-3647-7124-e053-2a91aa0a41bd.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

SENNA LAXATIVE
SENNOSIDES 8.6 MG
SENNOSIDES A AND B
MINERAL OIL
MICROCRYSTALLINE CELLULOSE
HYPROMELLOSES
CROSCARMELLOSE
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
MAGNESIUM STEARATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
11673-191	11673-191-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SENNOSIDES A AND B	1B5FPI42EN	ACTIB
MINERAL OIL	T5L8T28FGP	IACT
MICROCRYSTALLINE CELLULOSE	OP1R32D61U	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
CROSCARMELLOSE	029TFK992N	IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	O7TSZ97GEP	IACT
MAGNESIUM STEARATE	70097M6I30	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SENNA LAXATIVE	SENNOSIDES 8.6 MG	TARGET CORPORATION	7cab058f-3647-7124-e053-2a91aa0a41bd	2024-08-22	Warnings	Exact identifier ndc (package): 11673-191-01 ndc (product): 11673-191 ndc11 (package): 11673019101 spl id: 203fe25d-3930-ec05-e063-6294a90a248e spl set id: 7cab058f-3647-7124-e053-2a91aa0a41bd

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.